John Snow understands that each case, and each client, requires its own approach, and partners with clients to develop a strategy to achieve their business goals in a cost-efficient manner. He practices law exclusively in the field of intellectual property, concentrating in the areas of pharmaceutical, biochemical, chemical litigation, and opinions, with an emphasis in patent litigation and consulting arising under the Hatch-Waxman Act.
John has served as trial counsel for various patent litigations in U.S. federal courts and thrives on formulating trial strategies. He also has experience counseling biosimilar manufacturers and formulating strategies arising under the BPCIA. John has prepared and prosecuted U.S. and international patents in the chemical arts, as well as consulting and rendering opinions on patentability, infringement, validity, and enforceability.
Prior to becoming a lawyer, John worked as a Temporary Bioanalytical Chemist at Pfizer Global Research and Development, developing analytical methods and analyzing biological samples by Liquid Chromatography/Mass Spectrometry.
Also prior to practicing law, John worked in the University of Michigan Health System’s Geriatrics Department, operating multiple High Performance Liquid Chromatography operations with Ultraviolet-/Visible, electrochemical, and radiochemical detection, performing protein isolations, radioligand binding assays, and radioimmunoassays, and managing the operation of a clinical laboratory, including regulatory record keeping.
John also has experience with technology licensing and in patent interference proceedings.